GlassScriptPhysician profile
Shanda M Powell
NPI 1003635400
$714.12
in general payments reported to CMS, 2019-2025
16 companies · $691 in 2025
The $691 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $22.67 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $107.23 | 2025 | |
| Lilly USA, LLC | $79.52 | 2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $79.37 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $76.37 | 2025 | Airsupra, Breztri |
| Novo Nordisk INC | $55.08 | 2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $46.70 | 2025 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $44.25 | 2025 | Rexulti |
| Sonex Health, INC. | $37.02 | 2025 | Sx-One Microknife |
| Pfizer INC. | $34.54 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.48 | 2025 | Jardiance |
| Axsome Therapeutics, INC. | $24.15 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $23.58 | 2025 | Gardasil 9, Enflonsia, Capvaxive |
| Inspire Medical Systems, INC. | $22.67 | 2024 | Inspire |
| Medtronic, INC. | $16.89 | 2025 | Inceptiv |
| Amgen INC. | $16.76 | 2025 | Repatha, Otezla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $15.51 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanda Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.